The Claim
Circulating osteoprotegerin levels are correlated with intraplaque osteoprotegerin expression and the presence of osteoid metaplasia in carotid plaques, indicating that plasma osteoprotegerin reflects the biological state of carotid plaque stability.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Higher levels of osteoprotegerin in the blood are associated with higher levels of osteoprotegerin inside carotid plaques and the presence of bone-like tissue in those plaques, suggesting that blood osteoprotegerin levels indicate the stability of carotid plaques.
See the scientific wording
Circulating osteoprotegerin levels correlate with both intraplaque OPG and the presence of osteoid metaplasia, suggesting plasma OPG may reflect the biological state of carotid plaque stability rather than general disease severity.
Specialized cells around blood vessels turn into bone-forming cells when exposed to inflammation and bone-building signals. These cells release a protein that blocks another protein responsible for breaking down bone. As a result, bone-like tissue builds up inside artery plaques instead of being broken down, making the plaques harder and less likely to rupture. The same protein also enters the bloodstream, so its level in the blood matches how much bone-like tissue is forming inside the plaque.
What the research says
1 studyHigher levels of a protein called OPG in the blood are linked to more bone-like tissue and more OPG inside dangerous artery plaques—and these plaques are less likely to cause strokes. So, blood OPG levels may tell us how stable a plaque is, not just how bad the overall disease is.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.